![Sandra Calvin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 31/08/2026
Sandra Calvin is currently Chief Accounting Officer & Senior Vice President at Travere Therapeutics, Inc., a position held since 2014.
Ms. Calvin completed undergraduate studies at San Diego State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/04/2026 | 42.353 ( 0,05 % ) | 3 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/12/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
